臨床試驗

RNS System LGS Feasibility Study

NCT：NCT05339126 · ACTIVE_NOT_RECRUITING

NCT IDNCT05339126

狀態ACTIVE_NOT_RECRUITING

開始日期2022-10-04

完成時間2026-12-31

SponsorNeuroPace (INDUSTRY)

First posted2022-04-21

Last updated2026-09-15

簡要摘要

To generate preliminary safety and effectiveness data for brain-responsive neurostimulation of thalamocortical networks as an adjunctive therapy in reducing the frequency of generalized seizures in individuals 12 years of age or older with Lennox Gastaut Syndrome (LGS) who are refractory to antiseizure medications. The intent is to determine the feasibility and the optimal design of a subsequent pivotal study in order to expand the indication for use for the RNS System as a treatment for patients with medically intractable LGS.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。